Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification
This article is from
The Cancer Letter
archive.
Vol. 07 No. 15 | April 10, 1981
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
MSK, Fox Chase Volunteer to Limit Their Core Grants To Let Others Grow
June 29, 1990
TCL Archive
$2-A-Pack Cigarette Tax A “Significant Deterrent,” NCAB Resolution Says
October 8, 1993
TCL Archive
No Protective Effect From Long-Term Vitamin E or C
November 28, 2008
TCL Archive
Society Support Program for Training Cytotechnologists
November 29, 1991
TCL Archive
NCI Viewed As NIH’s ‘Administrative Reserve,” Broder Tells Directors
July 12, 1991
TCL Archive
FDA Approves Avastin Combination For Late-Stage Cervical Cancer
August 29, 2014